Radiation-induced Trismus and Related Measures of Patient Life Quality
Radiation therapy (RT) and concurrent chemoradiotherapy (CCRT), with or without surgery, are the established current standard treatment modalities for patients with head and neck cancers (HNC). Radiation-induced trismus (RIT), a serious side effect of RT or CCRT, can affect 5% to 69% of HNC patients, depending on the primary...
Read More
Routine Assessment of Health Related Quality of Life in Head & Neck Cancer Patients: A 10 Years’ Experience
In the field of head and neck oncology, clinical outcomes are often employed. Clinician-reported outcome assessments (health professionals), observer-reported outcome assessments (caregivers), and patient-reported outcome assessments are the three categories that clinical outcome evaluations fall under (patient or proxies). Based on a decade of experience, we identified the following...
Read More
Multinational Trends and Applications Considering Oncologic Risk Potential in Autologous Fat Grafting in the Face and Neck
Since there is more evidence to support its usage, autologous fat grafting (AFG) is becoming more used in cosmetic and reconstructive surgeries. We wanted to analyse present harvesting and processing strategies for AFG in the craniofacial area. To determine the clinical impact of oncological risk, we performed a study...
Read More
Polymorphism in EGFR Gene and its Association in Head and Neck Cancer Patients with Tobacco and Alcohol Consuming Habits
The epidermal growth factor receptor (EGFR) single nucleotide polymorphism (SNP) is important for disease progression and targeted therapy in head and neck cancer (HNC). As a result, the goal of this study is to find mutations in the EGFR gene (exon 20) in HNC who have been exposed to...
Read More
Study on CD44 as a Cancer Stem Cell Marker for Head and Neck Squamous Cell Carcinoma
CD44, a hyaluronic acid cell-surface glycoprotein receptor, has been linked to tumour growth and progression, as well as being used as a Cancer Stem Cell (CSC) marker in head and neck squamous cell carcinoma (HNSCC). CD44’s prognostic usefulness, on the other hand, is still unknown. As a result, the...
Read More
Assessment and Evaluation of Dosage Accuracy for Monte Carlo Simulations of the Prowess Panther Radiotherapy Planning System for Head and Neck Cancer
The treatment preparation systems for radiotherapy dose measurements are used by medical physicists. The accuracy of the calculated dose relative to the dose measured with ion champers should be tested for every TPS in many cases before it can be used clinically. Goal/Object: The purpose of this study was...
Read More
Immunotherapy Using Mycobacterium w Vaccine in Locally Advanced Head and Neck Cancer: Illustrative Research
The oncological treatment has been advanced promisingly over the past decades. The patients may be treated with surgery, chemotherapy (CT), radiotherapy (RT) or combination of these treatment modalities. Immunotherapy for prevention and treatment of malignant disease is also in initial stage and has raised a hope that improving immune...
Read More